Literature DB >> 3863708

Mapping of transforming growth factor alpha gene on human chromosome 2 close to the breakpoint of the Burkitt's lymphoma t(2;8) variant translocation.

J E Brissenden, R Derynck, U Francke.   

Abstract

Transforming growth factors (TGFs) are defined as biologically active polypeptides which reversibly confer the transformed phenotype onto untransformed cultured cells. TGF-alpha shows sequence homology with epidermal growth factor and competes with epidermal growth factor for binding to the epidermal growth factor receptor, stimulating the phosphorylation of the receptor. TGF-alpha is secreted by many transformed cells and may be involved in embryonic development. A cloned human TGF-alpha gene was used to map the locus for the TGF-alpha precursor to the short arm of human chromosome 2, region 2p11----2p13, by Southern blotting techniques with DNA prepared from rodent X human somatic cell hybrids. These hybrids contained different subsets of human chromosomes and included a set with a translocation between human chromosomes 1 and 2 [t(1;2) (q32;q13)]. In situ hybridization of the TGF-alpha probe to normal human metaphase spreads confirmed these data and localized TGF-alpha more precisely to bands 2p11----2p13. Breakpoints in the variant Burkitt lymphoma translocation t(2;8) occur within these bands. Such a t(2;8) translocation could place TGF-alpha next to c-myc in band 8q24. The possibility is raised that TGF-alpha might contribute to tumor progression in these cases of Burkitt's lymphoma.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3863708

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  11 in total

1.  Molecular and bioenergetic differences between cells with African versus European inherited mitochondrial DNA haplogroups: implications for population susceptibility to diseases.

Authors:  M Cristina Kenney; Marilyn Chwa; Shari R Atilano; Payam Falatoonzadeh; Claudio Ramirez; Deepika Malik; Mohamed Tarek; Javier Cáceres Del Carpio; Anthony B Nesburn; David S Boyer; Baruch D Kuppermann; Marquis P Vawter; S Michal Jazwinski; Michael V Miceli; Douglas C Wallace; Nitin Udar
Journal:  Biochim Biophys Acta       Date:  2013-11-04

2.  Loss of heterozygosity suggests tumor suppressor gene responsible for primary hepatocellular carcinoma.

Authors:  K H Buetow; J C Murray; J L Israel; W T London; M Smith; M Kew; V Blanquet; C Brechot; A Redeker; S Govindarajah
Journal:  Proc Natl Acad Sci U S A       Date:  1989-11       Impact factor: 11.205

3.  Assignment of the T-cell differentiation gene MAL to human chromosome 2, region cen----q13.

Authors:  M A Alonso; D E Barton; U Francke
Journal:  Immunogenetics       Date:  1988       Impact factor: 2.846

4.  RFLPs for transforming growth factor alpha (TGFA) gene at 2p13.

Authors:  J C Murray; K H Buetow; G I Bell
Journal:  Nucleic Acids Res       Date:  1986-09-11       Impact factor: 16.971

5.  Human elastin gene: new evidence for localization to the long arm of chromosome 7.

Authors:  M J Fazio; M G Mattei; E Passage; M L Chu; D Black; E Solomon; J M Davidson; J Uitto
Journal:  Am J Hum Genet       Date:  1991-04       Impact factor: 11.025

6.  Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells.

Authors:  D A Zajchowski; V Band; D K Trask; D Kling; J L Connolly; R Sager
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

7.  Distribution of mRNA for human epiregulin, a differentially expressed member of the epidermal growth factor family.

Authors:  H Toyoda; T Komurasaki; D Uchida; S Morimoto
Journal:  Biochem J       Date:  1997-08-15       Impact factor: 3.857

8.  Transforming growth factor-alpha: characterization of the BamHI, RsaI, and TaqI polymorphic regions.

Authors:  J F Qian; J Feingold; C Stoll; E May
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

9.  A new type of transforming growth factor-beta, TGF-beta 3.

Authors:  R Derynck; P B Lindquist; A Lee; D Wen; J Tamm; J L Graycar; L Rhee; A J Mason; D A Miller; R J Coffey
Journal:  EMBO J       Date:  1988-12-01       Impact factor: 11.598

10.  Epidermal and transforming growth factor alpha in patients with breast tumours.

Authors:  H Gregory; C E Thomas; I R Willshire; J A Young; H Anderson; A Baildam; A Howell
Journal:  Br J Cancer       Date:  1989-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.